157 related articles for article (PubMed ID: 21365634)
1. Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.
Slattery ML; Lundgreen A; Herrick JS; Wolff RK; Caan BJ
Cancer; 2011 Sep; 117(18):4175-83. PubMed ID: 21365634
[TBL] [Abstract][Full Text] [Related]
2. Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.
Slattery ML; Lundgreen A; Herrick JS; Caan BJ; Potter JD; Wolff RK
Carcinogenesis; 2011 Mar; 32(3):318-26. PubMed ID: 21088106
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in bone morphogenetic protein and colon and rectal cancer.
Slattery ML; Lundgreen A; Herrick JS; Kadlubar S; Caan BJ; Potter JD; Wolff RK
Int J Cancer; 2012 Feb; 130(3):653-64. PubMed ID: 21387313
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk.
Slattery ML; Herrick JS; Lundgreen A; Wolff RK
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):57-69. PubMed ID: 21068203
[TBL] [Abstract][Full Text] [Related]
5. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in the TGFβ-signaling pathway influence expression of miRNAs in colon and rectal normal mucosa and tumor tissue.
Slattery ML; Trivellas A; Pellatt AJ; Mullany LE; Stevens JR; Wolff RK; Herrick JS
Oncotarget; 2017 Mar; 8(10):16765-16783. PubMed ID: 28061442
[TBL] [Abstract][Full Text] [Related]
7. Interleukin genes and associations with colon and rectal cancer risk and overall survival.
Bondurant KL; Lundgreen A; Herrick JS; Kadlubar S; Wolff RK; Slattery ML
Int J Cancer; 2013 Feb; 132(4):905-15. PubMed ID: 22674296
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer.
Slattery ML; Lundgreen A; Wolff RK; Herrick JS; Caan BJ
Dis Colon Rectum; 2012 May; 55(5):532-40. PubMed ID: 22513431
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
Slattery ML; Herrick JS; Lundgreen A; Fitzpatrick FA; Curtin K; Wolff RK
Carcinogenesis; 2010 Sep; 31(9):1604-11. PubMed ID: 20622004
[TBL] [Abstract][Full Text] [Related]
10. Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers.
Chun HK; Jung KU; Choi YL; Hong HK; Kim SH; Yun SH; Kim HC; Lee WY; Cho YB
Oncology; 2014; 86(3):159-69. PubMed ID: 24643220
[TBL] [Abstract][Full Text] [Related]
11. Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival.
Slattery ML; Lundgreen A; Bondurant KL; Wolff RK
Carcinogenesis; 2011 Nov; 32(11):1660-7. PubMed ID: 21859832
[TBL] [Abstract][Full Text] [Related]
12. MAP kinase genes and colon and rectal cancer.
Slattery ML; Lundgreen A; Wolff RK
Carcinogenesis; 2012 Dec; 33(12):2398-408. PubMed ID: 23027623
[TBL] [Abstract][Full Text] [Related]
13. Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.
Boone SD; Baumgartner KB; Baumgartner RN; Connor AE; Pinkston CM; John EM; Hines LM; Stern MC; Giuliano AR; Torres-Mejia G; Brock GN; Groves FD; Kerber RA; Wolff RK; Slattery ML
Breast Cancer Res Treat; 2013 Sep; 141(2):287-97. PubMed ID: 24036662
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.
Slattery ML; Lundgreen A; Welbourn B; Corcoran C; Wolff RK
PLoS One; 2012; 7(5):e37312. PubMed ID: 22615972
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis.
Slattery ML; Herrick JS; Bondurant KL; Wolff RK
Int J Cancer; 2012 Jun; 130(12):2974-80. PubMed ID: 21792899
[TBL] [Abstract][Full Text] [Related]
16. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway.
Watanabe Y; Kinoshita A; Yamada T; Ohta T; Kishino T; Matsumoto N; Ishikawa M; Niikawa N; Yoshiura K
J Hum Genet; 2002; 47(9):478-83. PubMed ID: 12202987
[TBL] [Abstract][Full Text] [Related]
17. The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study.
Slattery ML; Lundgreen A; Stern MC; Hines L; Wolff RK; Giuliano AR; Baumgartner KB; John EM
Cancer Causes Control; 2014 Mar; 25(3):293-307. PubMed ID: 24337772
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival.
Slattery ML; Curtin K; Poole EM; Duggan DJ; Samowitz WS; Peters U; Caan BJ; Potter JD; Ulrich CM
Int J Cancer; 2011 Jun; 128(11):2726-34. PubMed ID: 20949557
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H
Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic Translation Initiation Factor 4E Is a Feed-Forward Translational Coactivator of Transforming Growth Factor β Early Protransforming Events in Breast Epithelial Cells.
Decarlo L; Mestel C; Barcellos-Hoff MH; Schneider RJ
Mol Cell Biol; 2015 Aug; 35(15):2597-609. PubMed ID: 25986608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]